![](http://cdn.i.haymarketmedia.asia/?n=finance-asia%2fcontent%2fshutterstock_1813360075.jpg&h=410&w=728&q=75&v=5f99a4b43f&c=1)
Mubadala-backed Kelix Bio seals MENA insulin manufacturing deal
The undisclosed deal for DiabTec, struck with Jalphur, gives the firm a MENA manufacturing base, as Kelix Bio continues its acquisition spree.
January 16, 2025